NCT05497908

Brief Summary

Key questions of this feasibility trial will be the feasibility of performing the TAP block in XLIF patients, screen for safety of the block and preliminary investigate the influence on pain control and quality of recovery. The investigators hypothesize that visualization of lateral TAP will be superior to visualization of posterior TAP, protocol adherence and safety profile to be excellent and both blocks to be superior in terms of analgesia compared to no block.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 11, 2022

Completed
22 days until next milestone

Study Start

First participant enrolled

September 2, 2022

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 23, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 23, 2024

Completed
Last Updated

September 27, 2024

Status Verified

September 1, 2024

Enrollment Period

2.1 years

First QC Date

July 28, 2022

Last Update Submit

September 26, 2024

Conditions

Keywords

eXtreme Lateral Interbody Fusion (XLIF) surgerytransversus abdominis plane (TAP) block

Outcome Measures

Primary Outcomes (1)

  • Identification rate of the correct transverse abdominis plane block

    Identification rate of the correct transverse abdominis plane block by ultrasound as assessed by a five-point-scale which can be found as supplement (very good -good - acceptable -poor - very poor)

    immediately after the surgery

Secondary Outcomes (10)

  • Total morphine consumption

    12 hours after surgery

  • Patient recruitment rate

    through study completion, an average of 1 year

  • Adherence rate to protocol

    12 hours after surgery

  • total operation room time

    during the surgery

  • Assessment of the number of patients with local anesthestia systemic toxicity (LAST)

    during the stay at the PACU

  • +5 more secondary outcomes

Study Arms (3)

Transversus abdominis plane (TAP) block via lateral approach

EXPERIMENTAL

This group receives a Transversus abdominis plane (TAP) block via lateral approach

Procedure: TAP block via lateral approach

Transversus abdominis plane (TAP) block via posterior approach

EXPERIMENTAL

This group receives a Transversus abdominis plane (TAP) block via posterior approach

Procedure: TAP block via posterior approach

Control group

NO INTERVENTION

The control group receives no TAP block.

Interventions

TAP block via lateral approach

Transversus abdominis plane (TAP) block via lateral approach

TAP block via posterior approach

Transversus abdominis plane (TAP) block via posterior approach

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • Scheduled for elective lumbar XLIF surgery
  • level
  • multilevel
  • Patient being able to give informed consent
  • Patient being able to understand and use the PCIA system
  • Body Mass Index (BMI) ≤ 35 kg/m2

You may not qualify if:

  • \- Refusal to participate
  • Chronic strong opioid use (WHO analgesic ladder step 3)
  • Allergy to local anesthetics
  • Antecedents of lumbar back surgery
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jessa Hospital

Hasselt, Limburg, 3500, Belgium

Location

MeSH Terms

Conditions

Pain, PostoperativeBites and Stings

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsPoisoningChemically-Induced DisordersWounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Stafmember Anesthesiology and Intensive Care, Head of Science department Anesthesiology and Intensive Care

Study Record Dates

First Submitted

July 28, 2022

First Posted

August 11, 2022

Study Start

September 2, 2022

Primary Completion

September 23, 2024

Study Completion

September 23, 2024

Last Updated

September 27, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations